About Us
Experienced CRO with a Sponsor's perspective
Why aCROss Medical?
aCROss Medical is not just another CRO.
We are a founder-led team built by people who have been on the sponsor side, responsible for timelines, budgets, investors, and outcomes. That experience shapes everything we do.
Our team brings together local and international experts, all medically trained (MD), with deep, hands-on experience running clinical trials across Georgia, Armenia, Israel, and Uzbekistan in pharma, medical devices, and advanced therapies (ATMPs).
But what really makes us different is not where we work. It is how we work.
We do not hide behind processes or pass things between departments. We stay close. We think with you. We take responsibility.
We understand what is at stake in every study, not just operationally, but for the company behind it and the patients waiting for it.
That is why partners choose us when timelines are tight, recruitment is challenging, or when they simply need a team that will treat their study as their own.
We started aCROss Medical because we saw how startups struggled with CROs that didn't truly understand their challenges. As former sponsors ourselves, we've sat on the other side of the table - managing budgets, fighting enrollment delays, navigating unfamiliar regulatory systems. That experience changed how we work. We don't just run trials. We anticipate problems before they happen, because we've lived them.
Every study we take on is personal. Our physicians lead from the front, our teams are on the ground, and our promise is simple: your study matters to us as much as it matters to you.
Watch Dr. Solberg presents aCROss Medical at LSI Europe '25
aCROss Medical is defined by our people and how we work together. Every project we undertake is driven by our goal to provide meaningful results for partners, focusing on solutions that make a real impact. Every voice is valued, and what sets us apart is not just our achievements, but the collaborative, solution-focused approach we bring to each project.
What I value most about aCROss Medical is the people. The trust, collaboration, and shared commitment to excellence create an environment where we support one another and deliver the highest quality for every client and every study.
As a Medical Monitor, I focus on patient safety and supporting teams through every challenge in a study. What makes aCROss Medical special to me is the people - the trust, care and dedication we bring every day. We don't just follow protocols; we truly stand behind every decision we make. There is a real sense of responsibility for each patient and each study. That human connection is what makes our work meaningful.
Dr. Yoram Solberg, MD, PhD
Chief Medical Officer
Dr. Yoram Solberg, MD, PhD, is an ophthalmologist and clinical development executive. He has extensive experience leading medical, clinical, and regulatory activities for international clinical research programs.
Before joining aCROss Medical, he served as VP Clinical and Medical Affairs at BELKIN Vision, where he led the company's pivotal international glaucoma trial, leading to CE and FDA approvals and commercial-stage activities. Earlier, he spent more than 15 years at BrainsGate, managing multinational clinical programs in acute ischemic stroke, including large pivotal randomized trials across 73 sites in 18 countries with more than 1,400 patients enrolled.
His work has included clinical study management, safety oversight, KOL and steering committee management, regulatory submissions, publication strategy, and close collaboration with leading medical centers worldwide.
Dr. Solberg holds an MD and PhD, both summa cum laude, from Ben-Gurion University and has a strong academic background in molecular neurobiology and ophthalmology, supported by numerous academic prizes, honors, scholarships, and research grants. He is an inventor on several patents and an author or co-author of over 40 scientific manuscripts, as well as additional proceedings and book chapters, in ophthalmology, neurology, stroke, and medical device development.
Monika Zalinian, MD
Medical Monitor
Dr. Monika Zalinian is an ophthalmologist, clinical researcher, and Medical Monitor with extensive experience in clinical trials and medical oversight. She is currently pursuing a PhD in Ophthalmology and combines clinical expertise with a strong background in academic research and medical education.
Her areas of expertise include glaucoma, retinal diseases, advanced ophthalmic diagnostics, and laser therapies, supported by international clinical training and research experience. Throughout her career, Dr. Zalinian has contributed to numerous clinical studies, collaborating closely with investigators, sponsors, and study teams to ensure scientific integrity, patient safety, regulatory compliance, and high-quality study conduct.
As a Medical Monitor, she provides medical oversight, safety assessments, eligibility review, protocol guidance, and clinical support throughout all stages of clinical development. Her combination of therapeutic expertise, academic leadership, and hands-on clinical research experience strengthens aCROss Medical's ability to deliver high-quality clinical trial support and medical oversight for international studies.
Tatia Mamadashvili, LL.B., MPA
Regional Manager
Tatia Mamadashvili is a clinical research professional with extensive experience in project coordination, operational management, stakeholder engagement, and international collaboration. At aCROss Medical, she supports the planning and execution of clinical research activities, working closely with sponsors, investigators, study sites, and project teams to facilitate the successful delivery of clinical trials.
Prior to joining aCROss Medical, Tatia held positions with leading international organizations, including UN Women and British Petroleum (BP), where she managed complex projects and information management initiatives in multicultural and multidisciplinary environments. Her diverse professional background has provided her with strong organizational, communication, and problem-solving skills that contribute to the effective management of clinical research programs.
Tatia holds a Bachelor of Laws (LL.B.) from Georgian American University and a Master of Public Administration (MPA) from the Georgian Institute of Public Affairs (GIPA). Her background in law, administration, and operations brings a valuable perspective to clinical research management, supporting aCROss Medical's commitment to delivering high-quality services to sponsors and study partners worldwide.
Tamara Khidesheli, MD, PhD
Senior Project Manager
Tamara Khidesheli is a Senior Project Manager with more than 22 years of experience in clinical research and over 15 years of prior clinical practice as a cardiologist and radiologist. She has extensive experience managing international clinical trials across a broad range of therapeutic areas.
Since 2018, Tamara has served as both Global and Supportive Project Manager, leading cross-functional teams and overseeing all aspects of study execution from start-up through closeout. She has participated in numerous sponsor audits and regulatory inspections, including FDA inspections, and brings strong expertise in project leadership, operational excellence, regulatory compliance, and inspection readiness.
Tamara holds an MD and PhD and is a board-certified Cardiologist and Radiologist.
Therapeutic Expertise
20+ Years Experience
Over two decades of experience in running clinical studies across multiple phases and therapeutic areas.
Phases I - IV
Full phase coverage from first-in-human through post-marketing studies.
200+ Clinical Centers
Long lasting professional relationships with over 200 study-skilled clinical centers and hospital networks.
95% Study Success Rate
95% of studies met or exceeded performance plans. Multiple successful audits and inspections.
70+ Completed Trials
Over 70 clinical trials completed across pharma (Phase I-IV), medical devices (FIH-Pivotal) and advanced therapy (ATMP) studies.
Global Clients
Partners range from early-stage startups to large corporates across international markets.
Therapeutic Areas
Full Service Offerings
Comprehensive clinical trial services from study initiation through close-out.